BiopharmaTrend.com

A fresh viewpoint on drug discovery, pharma, and biotech

Subscribe | Become an author | Author LogIn

Biopharma Insights


Three Insights For Immuno-oncology Drug Discovery

   by Alfred Ajami    5424

Immunotherapies are hot property. Immuno-oncology is the crown jewel. But the road to riches, and more importantly cancer cures, is now crowded and full of potholes. Drug hunters need to look ahead, beyond the discovery process itself, to the reality of the many impediments that will confront drug candidates as they proceed towards the clinic in today's landscape. Here, I present three insights from current events, the third one taking a contrarian position.

8 Biopharma Trends and Top Startups to Follow in 2017

   by Andrii Buvailo    7800

Pharmaceutical industry is rapidly evolving, influenced by emerging novel technologies and recent advances in Life Sciences and Big Data analysis, new government policies and regulations, and a changing market conjuncture.

Let’s review some of the most powerful trends that will dominate the industry in 2017 and promising biopharmaceutical startups riding their waves.

The Power Of Machine Learning For Drug Discovery

   by Andrii Buvailo    4232

An IBM’s executive Deborah DiSanzo just announced a collaboration with a pharmaceutical giant Pfizer to speed up anticancer drug discovery. This is yet another sign of a technological transformation unfolding in biopharmaceutical industry.

The newly formed partnership will bring the power of IBM’s supercomputer Watson and its artificial intelligence system to help researchers at Pfizer advance “immuno-oncology”, a potentially promising area for cancer research.